[go: up one dir, main page]

BG33296A3 - Метод за получаване на производни на 4- дезацетил- винкалевкобластин с- 3- карбоксихидразид - Google Patents

Метод за получаване на производни на 4- дезацетил- винкалевкобластин с- 3- карбоксихидразид

Info

Publication number
BG33296A3
BG33296A3 BG056469A BG5646979A BG33296A3 BG 33296 A3 BG33296 A3 BG 33296A3 BG 056469 A BG056469 A BG 056469A BG 5646979 A BG5646979 A BG 5646979A BG 33296 A3 BG33296 A3 BG 33296A3
Authority
BG
Bulgaria
Prior art keywords
obtaining
derivatives
vincalevcoblastine
dezacetyl
carboxyhydrazid
Prior art date
Application number
BG056469A
Other languages
English (en)
Inventor
George Cullinan
Koert Gerzon
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company
Publication of BG33296A3 publication Critical patent/BG33296A3/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C07D519/04—Dimeric indole alkaloids, e.g. vincaleucoblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

Метод за получаване на охарактеризирани и доказани в описанието производни на 4-дезацетил-винкалевкобластин с-3-карбоксихидразид с обща формула патентните претенции са формулирани в 5 точки
BG056469A 1978-04-20 1979-04-20 Метод за получаване на производни на 4- дезацетил- винкалевкобластин с- 3- карбоксихидразид BG33296A3 (bg)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/899,032 US4166810A (en) 1978-04-20 1978-04-20 Derivatives of 4-desacetyl VLB C-3 carboxyhydrazide

Publications (1)

Publication Number Publication Date
BG33296A3 true BG33296A3 (bg) 1983-01-14

Family

ID=25410402

Family Applications (3)

Application Number Title Priority Date Filing Date
BG056469A BG33296A3 (bg) 1978-04-20 1979-04-20 Метод за получаване на производни на 4- дезацетил- винкалевкобластин с- 3- карбоксихидразид
BG056470A BG33297A3 (bg) 1978-04-20 1979-04-20 Метод за получаване на производни на 4- дезацетил- винкалевкобластин с- 3- карбоксихидразид
BG043323A BG33294A3 (bg) 1978-04-20 1979-04-20 Метод за получаване на антитуморни производни на 4-дезацетил vlвс-3 карбоксхидразид

Family Applications After (2)

Application Number Title Priority Date Filing Date
BG056470A BG33297A3 (bg) 1978-04-20 1979-04-20 Метод за получаване на производни на 4- дезацетил- винкалевкобластин с- 3- карбоксихидразид
BG043323A BG33294A3 (bg) 1978-04-20 1979-04-20 Метод за получаване на антитуморни производни на 4-дезацетил vlвс-3 карбоксхидразид

Country Status (32)

Country Link
US (1) US4166810A (bg)
EP (1) EP0005051B1 (bg)
JP (1) JPS54141798A (bg)
AR (1) AR228940A1 (bg)
AT (1) AT369010B (bg)
AU (1) AU527109B2 (bg)
BE (1) BE875652A (bg)
BG (3) BG33296A3 (bg)
CA (1) CA1097629A (bg)
CH (1) CH643269A5 (bg)
CS (3) CS218583B2 (bg)
DD (1) DD143075A5 (bg)
DE (1) DE2964130D1 (bg)
DK (1) DK147484C (bg)
EG (1) EG14867A (bg)
ES (2) ES479754A1 (bg)
FI (1) FI791286A (bg)
FR (1) FR2423495A1 (bg)
GB (1) GB2019396B (bg)
GR (1) GR69987B (bg)
HU (1) HU181431B (bg)
IE (1) IE48213B1 (bg)
IL (1) IL57168A (bg)
LU (1) LU81166A1 (bg)
NZ (1) NZ190213A (bg)
PH (1) PH14163A (bg)
PL (3) PL125470B1 (bg)
PT (1) PT69496A (bg)
RO (3) RO81037A (bg)
SU (3) SU893135A3 (bg)
YU (1) YU93179A (bg)
ZA (1) ZA791856B (bg)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4322351A (en) * 1980-08-25 1982-03-30 Eli Lilly And Company Antineoplastic 4'-formylamino and 4'-acetylamino VLB, and derivatives thereof
DE3483336D1 (de) * 1983-03-30 1990-11-08 Lilly Industries Ltd Vincaleukoblastin-derivate.
US4667030A (en) * 1985-06-17 1987-05-19 Eli Lilly And Company Hydrazide succinimide derivatives of antineoplastic indole-dihydroindole alkaloids
US4675400A (en) * 1985-06-17 1987-06-23 Eli Lilly And Company Bifunctional derivatives of 4-desacetyl indole-dihydroindole alkaloids
US4801688A (en) * 1986-05-27 1989-01-31 Eli Lilly And Company Hydrazone immunoglobulin conjugates
US5043336A (en) * 1990-04-03 1991-08-27 Eli Lilly And Company Cyclic imide derivatives of 4-desacetyl VLB c-3 carboxhydrazide
US5043340A (en) * 1990-04-03 1991-08-27 Eli Lilly And Company Derivatives of 4-desacetyl VLB C-3 carboxhydrazide
DE60231868D1 (de) * 2001-04-24 2009-05-20 Purdue Research Foundation Folat-mimetika und deren folatrezeptorbindende konjugate
EP2060272A3 (en) * 2002-05-15 2009-05-27 Endocyte, Inc. Vitamin-mitomycin conjugates
NZ541846A (en) 2003-01-27 2008-12-24 Endocyte Inc Vitamin receptor binding drug delivery conjugates
US8288557B2 (en) 2004-07-23 2012-10-16 Endocyte, Inc. Bivalent linkers and conjugates thereof
JP5289935B2 (ja) * 2005-03-16 2013-09-11 エンドサイト，インコーポレイテッド プテロイン酸およびその結合体の合成と精製
KR20130113543A (ko) * 2005-08-19 2013-10-15 엔도사이트, 인코포레이티드 복수-약제 리간드 공액체
US20080280937A1 (en) * 2005-08-19 2008-11-13 Christopher Paul Leamon Ligand Conjugates of Vinca Alkaloids, Analogs, and Derivatives
US20100087370A1 (en) * 2007-02-14 2010-04-08 The General Hospital Corporation Modulation of nitric oxide signaling to normalize tumor vasculature
WO2008101231A2 (en) 2007-02-16 2008-08-21 Endocyte, Inc. Methods and compositions for treating and diagnosing kidney disease
CN104127878A (zh) * 2007-03-14 2014-11-05 恩多塞特公司 结合配体连接的微管溶素递药缀合物
US9877965B2 (en) 2007-06-25 2018-01-30 Endocyte, Inc. Vitamin receptor drug delivery conjugates for treating inflammation
CA2690943A1 (en) 2007-06-25 2008-12-31 Endocyte, Inc. Conjugates containing hydrophilic spacer linkers
EP2209374B1 (en) * 2007-10-25 2014-12-03 Endocyte, Inc. Tubulysins and processes for preparing
WO2011027786A1 (ja) * 2009-09-07 2011-03-10 ニプロパッチ株式会社 経皮吸収型製剤
US10080805B2 (en) 2012-02-24 2018-09-25 Purdue Research Foundation Cholecystokinin B receptor targeting for imaging and therapy
US20140080175A1 (en) 2012-03-29 2014-03-20 Endocyte, Inc. Processes for preparing tubulysin derivatives and conjugates thereof
EA201590622A1 (ru) 2012-10-16 2015-10-30 Эндосайт, Инк. Конъюгаты для доставки лекарственного средства, содержащие не встречающиеся в природе аминокислоты, и способы применения

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3097137A (en) * 1960-05-19 1963-07-09 Canadian Patents Dev Vincaleukoblastine
US3205220A (en) * 1961-10-26 1965-09-07 Lilly Co Eli Leurosidine and leurocristine and their production
US3392173A (en) * 1964-03-09 1968-07-09 Lilly Co Eli Novel acyl derivatives of desacetyl-vincaleukoblastine and processes for their preparation
US3370057A (en) * 1964-04-27 1968-02-20 Lilly Co Eli Leurosine
US3387001A (en) * 1964-10-19 1968-06-04 Lilly Co Eli Novel aminoacyl esters of desacetyl vincaleukoblastine
US3887565A (en) * 1974-05-06 1975-06-03 Lilly Co Eli Vincadioline
US3890325A (en) * 1974-05-15 1975-06-17 Lilly Co Eli Leurocolombine
US3954773A (en) * 1974-11-21 1976-05-04 Eli Lilly And Company 4-Desacetoxyvinblastine
US3944554A (en) * 1975-01-09 1976-03-16 Eli Lilly And Company 4-Desacetoxy-3-hydroxyvinblastine
IL48685A (en) * 1975-01-09 1980-03-31 Lilly Co Eli Amides of vincadioline and vinblastine
US4029663A (en) * 1975-07-10 1977-06-14 Eli Lilly And Company Dimeric anhydro-vinca derivatives
US4115388A (en) * 1977-03-30 1978-09-19 Eli Lilly And Company 3'-Oxygenated derivatives of 4'-deoxy VLB "A" and "B" and related 1-formyl compounds

Also Published As

Publication number Publication date
JPS6245873B2 (bg) 1987-09-29
ES479753A1 (es) 1980-08-16
DK147484B (da) 1984-08-27
PL119416B1 (en) 1981-12-31
FR2423495B1 (bg) 1983-02-11
BG33294A3 (bg) 1983-01-14
DD143075A5 (de) 1980-07-30
CS218584B2 (en) 1983-02-25
AU4609779A (en) 1979-10-25
ES479754A1 (es) 1980-08-16
CS218585B2 (en) 1983-02-25
DK147484C (da) 1985-03-25
YU93179A (en) 1983-01-21
EP0005051A1 (en) 1979-10-31
RO80084A (ro) 1983-02-01
LU81166A1 (fr) 1979-09-07
IL57168A0 (en) 1979-07-25
CS218583B2 (en) 1983-02-25
IE790795L (en) 1979-10-20
AR228940A1 (es) 1983-05-13
US4166810A (en) 1979-09-04
GB2019396A (en) 1979-10-31
AT369010B (de) 1982-11-25
RO81114B (ro) 1983-01-30
DE2964130D1 (en) 1983-01-05
FR2423495A1 (fr) 1979-11-16
EP0005051B1 (en) 1982-12-01
HU181431B (en) 1983-07-28
ZA791856B (en) 1980-11-26
DK160679A (da) 1979-10-21
PT69496A (en) 1979-05-01
RO80084B (ro) 1983-01-30
BE875652A (fr) 1979-10-18
AU527109B2 (en) 1983-02-17
GR69987B (bg) 1982-07-22
PH14163A (en) 1981-03-19
SU1225490A3 (ru) 1986-04-15
CH643269A5 (fr) 1984-05-30
RO81037A (ro) 1983-02-01
IL57168A (en) 1983-10-31
SU1061698A3 (ru) 1983-12-15
RO81114A (ro) 1983-02-01
JPS54141798A (en) 1979-11-05
EG14867A (en) 1986-09-30
CA1097629A (en) 1981-03-17
PL215911A1 (bg) 1980-03-24
GB2019396B (en) 1982-09-15
NZ190213A (en) 1982-12-21
ATA291279A (de) 1982-04-15
FI791286A (fi) 1979-10-21
RO81037B (ro) 1983-01-30
IE48213B1 (en) 1984-10-31
BG33297A3 (bg) 1983-01-14
PL125470B1 (en) 1983-05-31
SU893135A3 (ru) 1981-12-23

Similar Documents

Publication Publication Date Title
BG31225A3 (bg) Метод за получаване на ациланилидни производни
BG31645A3 (bg) Метод за получаване на фенетаноламини
BG31497A3 (bg) Метод за получаване на 4-амино-5-алкил-сулфонил ортонизамиди
BG28708A3 (bg) Метод за получаване на имидазолови производни
BG33296A3 (bg) Метод за получаване на производни на 4- дезацетил- винкалевкобластин с- 3- карбоксихидразид
BG35189A3 (bg) Метод за получаване на производни на 6-бета-хидроксиалкилпенициланова киселина
BG31499A3 (bg) Метод за получаване на 1-винилтриазолови производни
BG34338A3 (bg) Метод за получаване на тиадиазолилцефалоспорини
BG32115A4 (bg) Метод за получаване на хидантоини
BG38333A3 (bg) Метод за получаване на заместени фенилкарбоксиоксими
BG28699A3 (bg) Метод за получаване на алкилендиаминови производни
BG36348A3 (bg) Метод за получаване на производни на тиенопиридинона
BG31498A3 (bg) Метод за получаване на пиридилиминометилбензолни производни
BG28574A3 (bg) Метод за получаване на 4 дифенилметилен 1 хидрокси бензол пиперидини
BG28565A3 (bg) Метод за получаване на пиролхиноксалинони и пиролбензодиазепинони
BG30021A3 (bg) Метод за получаване на имидазоизохинолин-диони
BG32116A3 (bg) Метод за получаване на 4''-амино-олеандомицинови производни
BG31947A3 (bg) Метод за получаване на ацетидинови производни
BG33284A3 (bg) Метод за получаване на пиридазинилхидразони
BG34455A3 (bg) Метод за получаване на производни на 7 бета- аминотиазолилацетамидо- 3- цефем- 4- карбоновата киселина
BG36347A3 (bg) Метод за получаване на производни на тиенопиридинона
BG35035A3 (bg) Метод за получаване на нитроалканолови производни
BG29285A3 (bg) Метод за получаване на 3-ди-n пропилацетокси бензодиазепин-2-они
BG31074A3 (bg) Метод за получаване на 1-оксадити ацефалоспорини
BG28577A3 (bg) Метод за получаване на триазолотиенодиазепин-1-они